Lupin's Generic Spiriva Launch Delayed As FDA Action Expected By August

Medisol Acquisition To Push Injectables Growth

FDA Approval Stamp
Lupin Awaits FDA Action On A Spiriva Generic • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business